107 related articles for article (PubMed ID: 37619660)
1. Potential of pre-operative MRI features in glioblastoma to predict for molecular stem cell subtype and patient overall survival.
Eckert F; Ganser K; Bender B; Schittenhelm J; Skardelly M; Behling F; Tabatabai G; Hoffmann E; Zips D; Huber SM; Paulsen F
Radiother Oncol; 2023 Nov; 188():109865. PubMed ID: 37619660
[TBL] [Abstract][Full Text] [Related]
2. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract][Full Text] [Related]
3. Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of
Rathore S; Akbari H; Bakas S; Pisapia JM; Shukla G; Rudie JD; Da X; Davuluri RV; Dahmane N; O'Rourke DM; Davatzikos C
Front Comput Neurosci; 2019; 13():81. PubMed ID: 31920606
[TBL] [Abstract][Full Text] [Related]
4. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
[TBL] [Abstract][Full Text] [Related]
5. Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.
Skaga E; Kulesskiy E; Potdar S; Panagopoulos I; Micci F; Langmoen IA; Sandberg CJ; Vik-Mo EO
Transl Oncol; 2022 Dec; 26():101535. PubMed ID: 36115076
[TBL] [Abstract][Full Text] [Related]
6. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
Steponaitis G; Tamasauskas A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
11. The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
Wang L; Babikir H; Müller S; Yagnik G; Shamardani K; Catalan F; Kohanbash G; Alvarado B; Di Lullo E; Kriegstein A; Shah S; Wadhwa H; Chang SM; Phillips JJ; Aghi MK; Diaz AA
Cancer Discov; 2019 Dec; 9(12):1708-1719. PubMed ID: 31554641
[TBL] [Abstract][Full Text] [Related]
12. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells.
Park MG; Seo S; Ham SW; Choi SH; Kim H
Oncol Lett; 2020 Aug; 20(2):1153-1162. PubMed ID: 32724355
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.
Sharma A; Bendre A; Mondal A; Muzumdar D; Goel N; Shiras A
Front Oncol; 2017; 7():146. PubMed ID: 28744448
[TBL] [Abstract][Full Text] [Related]
15. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
[TBL] [Abstract][Full Text] [Related]
17. Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells.
Stanzani E; Pedrosa L; Bourmeau G; Anezo O; Noguera-Castells A; Esteve-Codina A; Passoni L; Matteoli M; de la Iglesia N; Seano G; Martínez-Soler F; Tortosa A
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205341
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
Dénes A; Bontell TO; Barchéus H; Vega SF; Carén H; Lindskog C; Jakola AS; Smits A
PLoS One; 2023; 18(5):e0285732. PubMed ID: 37192181
[TBL] [Abstract][Full Text] [Related]
19. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
[TBL] [Abstract][Full Text] [Related]
20. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
